Amneal Pharmaceuticals (AMRX) Assets (2017 - 2026)

Amneal Pharmaceuticals has reported Assets for 10 years, with the latest figure at $3.8 billion in Q2 2026.

• On a quarterly basis, Assets rose 10.33% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $3.8 billion, a 10.33% increase from a year earlier, with the FY2025 full-year figure at $3.7 billion, up 5.05% from the prior year.
• Assets was $3.8 billion for Q2 2026 at Amneal Pharmaceuticals, up from $3.5 billion in the prior quarter.
• The five-year high for Assets was $4.0 billion in Q2 2022, with the low at $3.4 billion in Q1 2025.
• Average Assets over 5 years is $3.6 billion, with a median of $3.6 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Assets retreated 8.6% in 2023, then climbed 10.33% in 2026.
• Over 5 years, Assets stood at $3.8 billion in 2022, then fell by 8.6% to $3.5 billion in 2023, then gained by 0.83% to $3.5 billion in 2024, then rose by 5.05% to $3.7 billion in 2025, then gained by 2.67% to $3.8 billion in 2026.
• The last three Assets figures came in at $3.8 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.7 billion (Q4 2025), per Business Quant data.